Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-13

Clinical Trial Update: Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of iloperidone compared with placebo and an active control in adults with acute schizophrenia; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fanapt (iloperidone)

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2024-12-13